Moderna has become the latest drug company to apply for full FDA approval for its COVID-19 vaccine to use in people 18 or older.
June 2, 2021 -- Moderna on Tuesday became the latest drug company to apply for full FDA approval for its coronavirus vaccine to use in people 18 or older.“We look forward to working with the FDA and will continue to submit data from our phase III study and complete the rolling submission,” Stéphane Bancel, Moderna’s chief executive, said in aModerna’s vaccine was authorized for emergency use in December, which gave conditional approval of its use based on 2 months of safety data.
Full U.S. approval will allow the vaccine to stay on the market once the U.S. is no longer in a public health emergency. It will also allow the company to begin advertising the shots on TV and other media platforms.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna seeks full FDA approval for its Covid-19 vaccineAbout half of Americans having received at least one dose of a Covid-19 vaccine as more Covid-19 mandates and restrictions ease. Follow here for the latest.
Read more »
Dr. Osterholm breaks down Moderna request for full vaccine approval, Covid-19 case counts among unvaccinatedInfectious disease expert, Dr. Michael Osterholm, joined Stephanie Ruhle to discuss Moderna's request to the FDA for full U.S. approval of its Covid-19 vaccine and coronavirus case numbers among the unvaccinated. He says the country is moving in the right direction but warns that 'it's not time to let up.'
Read more »
Now proven against coronavirus, mRNA can do so much moreThe messenger RNA technology used to make Moderna's and Pfizer/BioNTech's wildly successful coronavirus vaccines is being tested not only in other vaccines, but as a cancer treatment, gene therapy and more.
Read more »
Moderna partners with Thermo Fisher to scale up COVID-19 vaccine productionModerna Inc (MRNA.O) said on Tuesday it had entered into an agreement with Thermo Fisher Scientific (TMO.N) for manufacturing and packaging its COVID-19 vaccine, as the U.S. vaccine maker looks to scale up production.
Read more »
WHO grants emergency approval to 2nd Chinese COVID vaccineThe World Health Organization has approved a second Chinese-made coronavirus vaccine for emergency use. WHO’s authorization means the Sinovac vaccine can be bought by donors and other U.N. agencies for use in poorer countries.
Read more »